Expanded hepatitis B reagent range

Hepatitis B is a liver disease caused by the hepatitis B virus. Although a vaccine has been available since 1982, it is estimated that a third of the world’s population has been infected during their lifetime. This infectious disease is still common today in China.

Virostat has expanded its offering of hepatitis B reagents including its Monotope and Omnitope antibodies and recombinant antigens. Specificities include surface antigen (HBsAg), HB core, HB ‘e’, pre-s1, pre-s2 and HB-X. Applications for these reagents include enzyme-linked immunosorbent assay (ELISA), Western blot, immunohistochemistry (IHC) and rapid tests.
www.virostat-inc.com
 

Other news

Upcoming Events

HUCBMS 2019

Technological University Dublin
3-4 September 2019

The Oxford Haematology in Obstetrics Postgraduate Course

St Edmund Hall, Queen's Lane, Oxford OX1 4AR
9-11 September 2019

IBMS Biomedical Science Congress

ICC, Birmingham
22-25 September 2019

Lab Innovations

NEC, Birmingham (Hall 12)
30 & 31 October 2019

Latest Issue

Pathology In Practice

Pathology In Practice

Jun 2019

Recent advances in cancer diagnostics

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.